FdaApplication

NDA 019865

Back to search

Identifiers

Properties

PropertyValue
applicant_nameLEGACY PHARMA INC SEZC
application_typeNDA
approval_date1992-10-30

Products (5)

ProductActive ingredientStrengthDosage form
BETAPACESOTALOL HYDROCHLORIDE320MGTABLET;ORAL
BETAPACESOTALOL HYDROCHLORIDE80MGTABLET;ORAL
BETAPACESOTALOL HYDROCHLORIDE120MGTABLET;ORAL
BETAPACESOTALOL HYDROCHLORIDE240MGTABLET;ORAL
BETAPACESOTALOL HYDROCHLORIDE160MGTABLET;ORAL

5 products